Last reviewed · How we verify

NCT03323320

Evaluation of Patient's Knowledge of Their NACO Treatment

Completed Last updated 27 February 2018
What this trial tests

trial in Anticoagulant in 51 participants. Completed in 1 November 2017.

Timeline
5 December 2016
Primary endpoint
31 March 2017
1 November 2017

Quick facts

Lead sponsorFondation Hôpital Saint-Joseph
StatusCompleted
Study typeOBSERVATIONAL
Enrollment51
Start date5 December 2016
Primary completion31 March 2017
Estimated completion1 November 2017
Sites1 location across France

Conditions studied

Sponsor

Fondation Hôpital Saint-Joseph — full company profile →

Who can join

18 and older, any sex, with Anticoagulant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

More than one million of patient receive anti vitamine K treatment which is the main cause of hospitalization. About 50 000 patient receive direct oral anticoagulant . The aim is to evaluate the patient's level of knowledge about their anticoagulant treatment and specially about the side effect

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anticoagulant

Currently open trials in the same condition.

Other Fondation Hôpital Saint-Joseph trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03323320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing